Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: Implications for Clinical Trial Design

被引：0
|
作者：
Montorsi, Francesco [1 ]
Moschini, Marco [1 ]
Necchi, Andrea [1 ]
Deho, Federico [1 ]
Gandaglia, Giorgio [1 ]
Briganti, Alberto [1 ]
机构：
[1] IRCCS Osped San Raffaele, Div Oncol, Unit Urol, Urol Res Inst, Milan, Italy
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1528 / 1528
页数：1
相关论文
共 50 条
  • [21] Utilization of Bacillus Calmette- Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages EDITORIAL COMMENT
    Bandari, Jathin
    Maganty, Avinash
    Davies, Benjamin J.
    UROLOGY, 2019, 124 : 125 - 126
  • [22] THE EFFECT OF LEVOFLOXACIN ON BACILLUS CALMETTE-GUERIN INDUCED TOXICITY IN PATIENTS WITH NONMUSCLE-INVASIVE BLADDER CANCER: RESULTS OF A RANDOMIZED, PROSPECTIVE, MULTICENTER STUDY.
    Numakura, Kazuyuki
    Tsuchiya, Norihiko
    Tsuruta, Hiroshi
    Saito, Mitsuru
    Inoue, Takamitsu
    Nariata, Shintaro
    Huang, Mingguo
    Satoh, Shigeru
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2016, 195 (04): : E805 - E805
  • [23] Effectiveness of the Moreau strain of Bacillus Calmette-Guerin (BCG) for nonmuscle invasive bladder cancer.
    Chade, Daher Cezar
    Machado, Andre
    Waksman, Ricardo
    Garcia, Guilherme
    Esteves, Paulo
    Adonias, Sanarelly
    Botelho, Luis
    Cordeiro, Mauricio
    Murta, Claudio
    Ribeiro-Filho, Leopoldo
    Sarkis, Alvaro
    Bastos, Diogo Assed
    Dzik, Carlos
    Srougi, Miguel
    Nahas, William Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [24] Re: Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction Bacillus Calmette-Guerin therapy
    Krajewski, Wojciech
    Zdrojowy, Romuald
    Kolodziej, Anna
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (06) : 346 - 347
  • [25] INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR NONMUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER - PATTERNS OF USE, AND IMPACT ON OUTCOMES
    Azer, S.
    Ranasinghe, W.
    Webb, C.
    Lioufas, P. A.
    Cetti, R.
    Frydenberg, M.
    Bolton, D.
    Appu, S.
    Sengupta, S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 40 - 40
  • [26] SYSTEMIC BACILLUS CALMETTE-GUERIN INFECTION, BCGITIS, IN PATIENTS TREATED BY INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR BLADDER-CANCER
    STEG, A
    LELEU, C
    DEBRE, B
    BOCCONGIBOD, L
    SICARD, D
    EUROPEAN UROLOGY, 1989, 16 (03) : 161 - 164
  • [27] Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model EDITORIAL COMMENT
    Kamat, Ashish M.
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2203 - 2203
  • [28] The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Sfakianos, John P.
    Kim, Philip H.
    Hakimi, A. Ari
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2014, 191 (02): : 341 - 345
  • [29] Bacillus Calmette-Guerin and bladder cancer
    Razack, Azad H. A.
    ASIAN JOURNAL OF SURGERY, 2007, 30 (04) : 302 - 309
  • [30] Endovesical Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in Kidney Transplant Recipients: Is It Safe and Efficacious?
    Prudhomme, Thomas
    Andras, Iulia
    Boissier, Romain
    Campi, Riccardo
    Hevia, Vital
    Territo, Angelo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (08) : 789 - 791
12345